- Published: 20 June 2017
- Written by Investor Ideas
- Published: 20 June 2017
- Written by Investor Ideas
Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficiently
LONDON, June 15, 2017 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, today announced a collaboration with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.
Wearables have the potential to address several challenges related to clinical trials and improve execution by increasing patients’ ability to participate, driving patient engagement, and creating more opportunities for decentralised trial sites. The PAREXEL-Sanofi collaboration is designed to further explore the potential of patient sensors and wearable devices to remotely collect patient data during clinical trials.
- Published: 15 June 2017
- Written by RealWire
Collaboration to enable a platform of open innovation
- Published: 15 June 2017
- Written by RealWire
CEO of US Gold Corp. (NASDAQ: $DRAM) Talks about Recent Update on Keystone Property and Why Geopolitical Factors Make this an exciting time for #Gold Investors
Point Roberts, WA, Delta BC –June 8, 2017 – Investorideas.com, a global news source covering leading sectors including mining stocks releases an exclusive podcast interview with Edward Karr, the President, CEO and Chairman of US Gold Corp. (NASDAQ: DRAM) following a recent update from the Company.
Read this release in full at http://www.investorideas.com/CO/DRAM/news/2017/06081CEO.asp
Hear the full interview with Edward Karr, President, CEO and Chairman of US Gold Corp
http://www.investorideas.com/Audio/Podcasts/060717-DRAM.mp3
- Published: 11 June 2017
- Written by Investor Ideas